Loading...
XKRX
249420
Market cap329mUSD
Oct 08, Last price  
14,020.00KRW
1D
-5.33%
1Q
-8.96%
Jan 2017
-14.77%
IPO
-30.19%
Name

Il Dong Pharmaceutical Co Ltd

Chart & performance

D1W1MN
XKRX:249420 chart
P/E
15.97
P/S
0.78
EPS
878.01
Div yield, %
—
Shrs. gr., 5y
4.78%
Rev. gr., 5y
0.18%
Revenues
566.93b
-7.81%
201,343,779,350460,650,814,930503,907,355,300517,467,682,000561,845,100,000560,131,626,000637,714,490,000600,757,840,000614,940,883,000566,933,738,000
Net income
27.66b
P
12,578,693,00019,841,042,00012,720,690,000-13,443,583,000-13,019,160,000-99,705,189,000-142,169,550,000-78,928,206,000-4,576,225,00027,664,424,000
CFO
18.95b
-33.02%
19,156,880,41073,724,186,54066,646,835,05041,365,650,00019,365,602,000-11,365,958,000-53,540,654,000-36,615,397,00028,292,776,00018,950,688,000
Dividend
Mar 30, 2026200 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ildong Pharmaceutical Co., Ltd., established in 1941 and headquartered in Seoul, South Korea, is a company dedicated to the development, production, and distribution of a wide array of pharmaceutical products. Its extensive portfolio includes various medications such as anti-diarrheal agents, antibiotics, antifungals, antivirals, antihistamines, anticancer drugs, NSAIDs, and pain relievers, along with essential vitamins, minerals, and nutritional supplements. The company also produces treatments for numerous bodily systems, including cardiovascular, central nervous, dental, endocrine, gastrointestinal, respiratory, topical, and urogenital health, as well as those for blood circulation. Beyond pharmaceuticals, Ildong offers raw material drugs, health foods, cosmetics, and specialized medical devices, such as scar treatment products. Their range also extends to unique treatments for conditions like osteoarthritis, wound care, artificial tears, and feminine hygiene products. In addition to its product offerings, the company manages licenses and provides contract manufacturing services. With a global reach, Ildong Pharmaceutical exports its products to approximately 20 countries. Furthermore, the company has entered into a strategic collaboration with Evotec SE, leveraging Evotec's INDiGO platform to accelerate the development of its proprietary projects.

Key people

Seong Gu Choi
Co-President, Director
Chief Financial Officer, Director
Deok Won Kang
Vice President
Yong Chan Bae
Managing Director · since 2023
Seok Je Cho
Managing Director
Seung Su Kim
Managing Director
Won Rang Kim
Managing Director
Sin Yeong Lee
Managing Director
Seok Jun Lee
Managing Director · since 2024
Managing Director · since 2024
Jeong Seop '
Internal Auditor
Ju Seong Park
Internal Auditor
Director · since 2024
Jae Jun Lee
President, Co-Chief Executive Officer, Director · since 2026
Co-Chief Executive Officer, Director · since 2026
Hui Dong Chae
Non-Executive Independent Director
Min Song
Non-Executive Independent Director
IPO date
Aug 31, 2016
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT